Quantcast Acelity - CMS Competitive bidding
MENU

CMS’ Competitive Bidding Program

The facts about Access to V.A.C.® Therapy in CMS’ Round 1 2017 and Round 2 Recompete CBAs

Medicare Patients still have access to ACTIV.A.C™ Negative Pressure Wound Therapy

Acelity is still committed to providing best-in-class clinical and product support for all patients across
the continuum of care.
 
 

KCI V.A.C.® Negative Pressure Wound Therapy Medicare Part B Reimbursement Facts:
 
  • V.A.C.® Therapy is still available to patients
  • V.A.C.® Therapy did not lose Medicare coverage
  • KCI is working with Contracted Suppliers to provide V.A.C.® Therapy for patients served in CMS Round 2 Recompete Competitive Bidding Areas (CBAs) 
 

From Hospital to Home, Clinicians are Confident in the Certainty of Acelity.

 

OVER

158,000

Medicare patients**
since competitive bidding was implemented in 2013

10M

wounds treated worlwide
with V.A.C.® THERAPY*
 
 
 

No impact to:
  • Managed Medicare
  • Medicaid
  • Private Insurance/MCO
  • Medicare Part B in other geographies not indicated on the map below

Questions

Contact your Acelity representative or the Acelity Reimbursement Hotline at 1-800-668-6812 for any questions on the CMS Round 2 Recompete.

Make better

Our mission is to change the practice of medicine with solutions that advance the science of healing, create economic value and improve patients’ lives.

Footer Navigation